Huons starts to export KRW 89 billion ‘lidocaine injections’ to the U.S.

Huons(CEO Ki-Ahn Eum), a subsidiary of Huons Global, will actively start to target the U.S. market for 1% Lidocaine 5mL Ample, an injection-type finished drug which acquired the new drug application(ANDA) from the U.S. FDA on the last 4^th.

Huons announced on the 8^th that the company signed a long-term supply agreement of total KRW 89.3 billion products with Spectra Medical for 2 years.

The tw...